Found: 27
Select item for more details and to access through your institution.
Humoral immunity to phlebovirus infection.
- Published in:
- Annals of the New York Academy of Sciences, 2023, v. 1530, n. 1, p. 23, doi. 10.1111/nyas.15080
- By:
- Publication type:
- Article
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30836-0
- By:
- Publication type:
- Article
Concordance of B‐ and T‐cell responses to SARS‐CoV‐2 infection, irrespective of symptoms suggestive of COVID‐19.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 11, p. 5217, doi. 10.1002/jmv.28016
- By:
- Publication type:
- Article
Molecular rationale for antibody- mediated targeting of the hantavirus fusion glycoprotein.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.58242
- By:
- Publication type:
- Article
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.985938
- By:
- Publication type:
- Article
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 6, p. 999, doi. 10.1111/bjh.17568
- By:
- Publication type:
- Article
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 796, doi. 10.1038/nsmb.2594
- By:
- Publication type:
- Article
Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023521
- By:
- Publication type:
- Article
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 11, p. 1, doi. 10.1371/journal.ppat.1009820
- By:
- Publication type:
- Article
Site-Selective Traceless Staudinger Ligation for Glycoprotein Synthesis Reveals Scope and Limitations.
- Published in:
- ChemBioChem, 2011, v. 12, n. 9, p. 1383, doi. 10.1002/cbic.201100125
- By:
- Publication type:
- Article
Broad neutralization coverage of HIV by multiple highly potent antibodies.
- Published in:
- Nature, 2011, v. 477, n. 7365, p. 466, doi. 10.1038/nature10373
- By:
- Publication type:
- Article
The HIV glycan shield as a target for broadly neutralizing antibodies.
- Published in:
- FEBS Journal, 2015, v. 282, n. 24, p. 4679, doi. 10.1111/febs.13530
- By:
- Publication type:
- Article
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection and vaccine antibody prevalence in a multi‐ethnic inner‐city antenatal population: A cross‐sectional surveillance study.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2023, v. 130, n. 9, p. 1135, doi. 10.1111/1471-0528.17508
- By:
- Publication type:
- Article
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
- Published in:
- Nature Communications, 2015, v. 6, n. 6, p. 7479, doi. 10.1038/ncomms8479
- By:
- Publication type:
- Article
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.ppat.1005110
- By:
- Publication type:
- Article
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 5, p. 1, doi. 10.1371/journal.ppat.1003342
- By:
- Publication type:
- Article
Cover Picture: Exploring and Exploiting the Therapeutic Potential of Glycoconjugates (Chem. Eur. J. 3/2006).
- Published in:
- Chemistry - A European Journal, 2006, v. 12, n. 3, p. 643, doi. 10.1002/chem.200690008
- By:
- Publication type:
- Article
Exploring and Exploiting the Therapeutic Potential of Glycoconjugates.
- Published in:
- Chemistry - A European Journal, 2006, v. 12, n. 3, p. 656, doi. 10.1002/chem.200500557
- By:
- Publication type:
- Article
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 236, p. 1, doi. 10.1126/scitranslmed.3008104
- By:
- Publication type:
- Article
Harnessing post-translational modifications for next-generation HIV immunogens.
- Published in:
- Biochemical Society Transactions, 2018, v. 46, n. 3, p. 691, doi. 10.1042/BST20170394
- By:
- Publication type:
- Article
Fc RECEPTOR-MEDIATED INFECTION OF MYELOID CELLS BY SARS-CoV-2.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 94
- By:
- Publication type:
- Article
Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
- Published in:
- Glycobiology, 2010, v. 20, n. 7, p. 812, doi. 10.1093/glycob/cwq020
- By:
- Publication type:
- Article
Translational Research in the Time of COVID-19—Dissolving Boundaries.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 9, p. 1, doi. 10.1371/journal.ppat.1008898
- By:
- Publication type:
- Article
Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies.
- Published in:
- Retrovirology, 2016, v. 13, p. 1, doi. 10.1186/s12977-016-0241-5
- By:
- Publication type:
- Article
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 10, p. 1, doi. 10.1371/journal.ppat.1010882
- By:
- Publication type:
- Article